Constructs of biotin mimetic peptide with CC49 single-chain Fv designed for tumor pretargeting

Gabriela Pavlinkova, Surinder K. Batra, David Colcher, Barbara J.M. Booth, Janina Baranowska-Kortylewicz

Research output: Contribution to journalArticlepeer-review

9 Scopus citations


Single-chain Fv constructs comprising a biotin mimetic peptide (BMP) and scFv of CC49 monoclonal antibody were produced to improve pretargeted radioimmunotherapy. BMP units that bind streptavidin were added to the carboxyl terminus of the CC49 VH region. An engineered scFvBMP monomer and a sc(Fv)2BMP dimer showed an excellent antigen recognition in vitro with a specific binding of 72±5 and 81±4%, respectively. Properties of 125I-sc(Fv)2BMP in mice bearing LS-174T xenografts were comparable to these of the parent 125I-sc(Fv)2. Complexing of scFvBMPs with streptavidin increased tumor targeting and gave exceptionally high tumor-to-blood values of 63±7 for 125I-sc(Fv)2BMP-streptavidin compared with 37±4 for sc(Fv)2BMP at 72h after administration. High tumor and negligible normal tissue levels of these novel pretargeting constructs indicate a great potential for pretargeted radioimmunotherapy.

Original languageEnglish (US)
Pages (from-to)353-362
Number of pages10
Issue number3
StatePublished - Mar 1 2003


  • Biotin mimetic peptide
  • Pretargeting radiotherapy
  • Single-chain antibody fragments
  • Streptavidin

ASJC Scopus subject areas

  • Biochemistry
  • Physiology
  • Endocrinology
  • Cellular and Molecular Neuroscience


Dive into the research topics of 'Constructs of biotin mimetic peptide with CC49 single-chain Fv designed for tumor pretargeting'. Together they form a unique fingerprint.

Cite this